What is the last grey market premium of Aakaar Medical Technologies IPO?

 Click

Listing Review: Will update on listing.

Subscription status of Aakaar Medical Technologies IPO

Aakar Medical IPO
(Day 1)

Price Rs. 72 Lot 1600 shares, Rs.27.00 Crore

QIB NII x RII x Total x Applications
0.33 0.59 0.30 0.37 249
Subscription Review:
Unimpressive flow of application till now.

Aakaar Medical Technologies IPO Allotment Link: 

 

What is the business of Aakaar Medical Technologies?

Aakaar Medical Technologies Limited is a fast-growing aesthetic medical company at the forefront of cosmetic innovation. With a curated portfolio of advanced products and cutting-edge devices, Aakaar serves the needs of dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists across India.

Specializing in Beauty, Backed by Science

Aakaar offers a comprehensive range of both in-house and internationally sourced brands—manufactured in India and imported from global leaders in aesthetic technology including South Korea, Spain, Italy, and Austria.

Its products are trusted by medical professionals who use them in clinical procedures and retail them directly to end consumers for at-home skincare and haircare regimens.

Diverse Product Portfolio

Its offerings cover a full spectrum of cosmetic and aesthetic needs:

  • Homecare & Professional Skincare Solutions
    Serums, creams, and treatments tailored for individual and clinical use.
  • Injectables & Contouring Products
    Designed for precision aesthetic enhancements.
  • Hair Care & Regrowth
    Hair growth serums, anti-hair loss solutions, and nutraceutical tablets.
  • Medifacial Kits
    Complete kits for rejuvenating, skin-brightening, and anti-aging treatments.
  • Advanced Medical Devices
    • Urinary incontinence therapy devices
    • Tattoo removal, pigmentation correction & skin rejuvenation systems
    • Laser hair reduction machines
    • Hair transplant equipment

Nationwide Reach & Expert Support

With a robust network of branches across India and a team of 90 trained sales and service professionals, Aakaar ensures timely support and seamless customer experience for thousands of aesthetic practitioners.

Operational Footprint

The company serves healthcare professionals in the following states:
Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.

Get more information about the company

Aakaar Medical Technologies IPO Details

Sector:

IPO opens on  20 June 2025
IPO closes on  24 June 2025
Issue Type Book Built Issue IPO
Issue Size 3750400 Shares /
Rs 27.00 Crore
* Fresh Issue 3750400 Shares /
Rs 27.00 Crore
* Offer for Sale –
Market Maker Portion 188800 Shares
Net offer to Public 3561600 Shares
Rs.25.64 Crores
Face Value per share Rs. 10
Price Band Rs. 68-72
Employee discount  Rs. 0 per share
Retail Lot Size  1600 Shares
Listing will at  NSE SME
Category Shares Offered % of offer Rs. In Cr.
Market Maker  188,800 5.03%  
QIB  1779,200 47.42%  
  Anchor Investors 1067,200 28.44%  
  QIB
(Ex. Anchor)
712,000 18.98%  
NII (HNI 536,000 14.29% 3.86
Retail  1248,000 33.29% 8.99
Total Shares 3752,000 100.00%  
RII portion will be oversubscribed by 780 forms
       
  Lot Shares Amount
RII-Min 1 1600 1,15,200
RII-Max 2 1600 1,15,200
HNI-Min 3 3200 2,30,400

Who are the Promoters of Aakaar Medical Technologies?

Dilip Ramesh Meswani and Bindi Dilip Meswani are the Promoters of the company

What are the Objects of Aakaar Medical Technologies IPO?

  1. Funding working capital requirements of the Company Rs. 20.35 Cr.
    2. General corporate purposes

Aakaar Medical Technologies Timetable

Tentative timetable

IPO opens on 20 June 2025
IPO Closes on 24 June 2025
IPO Allotment on  25 June 2025
Refund Initiation  26 June 2025
Credit of Shares 26 June 2025
Listing on 27 June 2025

Registered Office of the Company
Aakaar Medical Technologies Limited

801, Heritage Plaza,
Telli Galli Cross Road
Andheri (East),
Mumbai, Maharashtra, 400069

The Lead Manager of this IPO
Indorient Financial Services  ltd

Who is the Registrar to IPO?
BigShare Services Pvt ltd

Aakaar Medical Technologies IPO GMP grey market premium, review, Subscription, allotment, listing estimate

Aakaar Medical Technologies Financials

Period Ended 31-Mar-25 31-Mar-24 31-Mar-23
Assets 51.85 34.01 23.23
Revenue 61.76 46.27 32.88
Profit After Tax 6.04 2.87 2.15
EBITDA 0 0 0
Net Worth 23.2 12.53 9.66
Reserves and Surplus 12.78 11.84 8.96
Total Borrowing 22.74 15.06 5.87
Amount in Rs. Crore

Performance Indicators

KPI Values
ROCE 21.02%
Debt/Equity 0.98
RoNW 33.81%
PAT Margin 9.81
Price to Book Value 5.23
EPS Rs.5.79
PE Ratio 12.43

How Aakaar Medical Technologies IPO compares with the Peers?
There is no peer group listed company

# This is only coverage of News related to Grey Market Premium & subject to rates. We do not deal in grey market premium. We do not recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

Aakaar Medical Technologies IPO Review by Paresh Gordhandas, CA & Research Analyst.

Aakaar Medical Technologies Limited is one of India’s fastest-growing players in the aesthetic and cosmetic medical space. Positioned at the intersection of innovation and wellness, Aakaar delivers a premium portfolio of advanced medical devices and aesthetic solutions to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists nationwide.

With a sharp focus on quality, safety, and results, Aakaar offers a well-curated mix of in-house innovations and globally recognized brands, sourced from industry leaders across South Korea, Spain, Italy, and Austria—as well as high-quality products manufactured right here in India.


Financial Highlights & IPO Insights

The company’s financial performance has shown impressive momentum. In FY 2024–25, net profit surged to Rs.6.04 crore, more than doubling from Rs.2.87 crore in FY 2023–24. While this significant increase demonstrates strong growth potential, the sharp jump in the bottom line warrants closer scrutiny for sustainability.

  • IPO Size: Rs.25.64 crore — modest in scale, offering manageable risk for new investors.

  • Retail Quota: Rs.8.99 crore — could be fully subscribed with just 780 retail applications.

  • HNI Allocation: Rs.3.86 crore — suggesting limited competition in this category.

  • Valuation: Shares are being offered at a P/E multiple of 12.43, based on the FY25 profits—reasonable, but tied to the company’s ability to maintain its earnings growth.

Currently, no notable premium has been observed in the grey market, indicating muted pre-listing sentiment.

Conclusion

Aakaar Medical Technologies stands at the cusp of opportunity in a fast-evolving industry. While the company’s product mix, international partnerships, and rapid profit growth are attractive, the sharp rise in earnings and lack of grey market enthusiasm suggest that potential investors should proceed with balanced optimism and due diligence.

+ from fundamental angle: May apply 

+ from grey market angle: Not attractive

Quicklinks


 
Aakaar Medical Technologies
IPO 

 
Aakaar Medical Technologies
IPO

Leave a Reply

Your email address will not be published. Required fields are marked *